Dexamethasone dosing for children with acute asthma in the emergency department
Official title: Dosing of Steroids for Acute Asthma Given in the Emergency Department - a Pilot Randomised Feasibility Trial of Dexamethasone in Children
Run by Sheffield Children's NHS Foundation Trust · NCT07402707 · Data updated 2026-11-12
This study tests whether two different single doses of dexamethasone given in the emergency department help children aged 4–15 during an asthma attack.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 4 Years to 15 Years |
| Sex | All |
| Enrollment | 104 (estimated) |
| Sponsor | Sheffield Children's NHS Foundation Trust Academic / other |
| Locations | 1 site (Sheffield) |
| Status | Recruiting |
| Started | February 23, 2026 |
| Main results expected | August 31, 2026 |
| Study ends | August 31, 2026 |
| Registry record updated | April 23, 2026 |
| Trial ID | NCT07402707 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 4–15 who present to the Sheffield Children's ED with an asthma exacerbation where oral steroids are recommended and whose family can use available language support are ideal candidates.
✕Probably not a fit
Children with life‑threatening asthma, first‑time wheeze, recent steroid use, concomitant stridor, known difficult asthma, other conditions requiring steroids, or current involvement in other research are not eligible and are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized pilot compares two single oral doses of dexamethasone given in the ED to children aged 4–15 presenting with an asthma exacerbation. Investigators will compare the need for a repeat steroid prescription within two weeks after treatment and will record subsequent ED or GP visits and parent/child acceptability. Dexamethasone is used because it is well tolerated and can be given as a single dose rather than a multi-day course. As a feasibility trial, results will inform the design and size of a larger definitive study if needed.
Why it matters
Potential benefit: If successful, the trial could identify a single dexamethasone dose that reduces repeat steroid prescriptions and makes emergency treatment simpler and better tolerated for children.
How similar studies have gone: Previous trials and systematic reviews have found dexamethasone to be at least as effective as prednisolone for paediatric asthma exacerbations and better tolerated, so this dosing comparison builds on existing evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children aged 4-15 years (inclusive) presenting to the ED with an asthma exacerbation, where oral steroids are recommended by Trust/National guidelines. * Children whose parents/carers do not speak English will also be eligible provided they speak one of the common languages where an interpreter and Information Sheets are available (Slovakian, Arabic and Urdu). Exclusion Criteria: * Children who have been treated with oral or IV steroids in the last 2 weeks. * Hypersensitivity to the study drug. * Children who have concomitant stridor. * First episode of wheezing (not previously diagnosed as asthma). * Children with known difficult asthma who receive longer courses of steroids as standard. * Life threatening episode of asthma. * Children with other conditions that require them to have steroids when unwell. * Children who are involved in current research or have recently been involved in research prior to recruitment
Where it's running
-
Sheffield Children's NHS Foundation Trust
Sheffield, United Kingdom Recruiting
Study contacts
- Principal investigator: Judith Gilchrist — Sheffield Children's NHS Foundation Trust
- Study coordinator: Meena Balasubramanian
- Email: meena.balasubramanian@nhs.net
- Phone: 0114 3053136
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Dexamethasone and Spinal Block Duration in Lower Abdominal Surgery
This study tests whether giving dexamethasone before spinal anesthesia can lengthen how long the numbness lasts for adults having lower abdominal surgery.
-
Intraparotid injection of bupivacaine with dexamethasone after partial parotidectomy
This early-phase study tests whether a single intraparotid injection of bupivacaine with dexamethasone is safe and tolerable after partial parotidectomy for a benign tumor.
-
Olanzapine-based, dexamethasone-sparing antiemetic regimen for breast cancer patients with metabolic risk factors
This study tests whether an olanzapine-containing antiemetic plan can match the usual dexamethasone-containing approach in preventing delayed chemotherapy-induced nausea and vomiting for breast cancer patients with metabolic risk factors.
-
Liposomal Bupivacaine Plus Plain Bupivacaine vs Dexamethasone Plus Plain Bupivacaine for High-Risk Pain After Supraclavicular Brachial Plexus Block
This trial tests whether liposomal bupivacaine with plain bupivacaine can better control postoperative pain after distal radial fracture surgery in patients at high risk of severe pain, compared with dexamethasone plus plain bupivacaine.
-
Dexamethasone, Dexmedetomidine, or Both After Laparoscopic Gallbladder Surgery
This study tests whether dexamethasone, dexmedetomidine, or the combination help recovery of gut function after laparoscopic cholecystectomy.
-
Dexamethasone and Bupivacaine in a Shoulder Nerve Block: How It Affects Blood Levels
This study tests whether giving dexamethasone with a shoulder block affects the blood level of bupivacaine after a single injection.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.